Professional Documents
Culture Documents
PURPOSE: To analyze changes in intraocular pressure (IOP) after cataract surgery based on data
from the Swedish National Cataract Register (NCR).
SETTING: Ophthalmic surgery units in Sweden.
DESIGN: Prospective database study.
METHODS: Data for 2012 through 2014 were obtained prospectively from the NCR. The outcome
register of the NCR has collected data on IOP before and a mean of 37.7 days G 29.1 (SD) after
cataract surgery since 2012.
RESULTS: The analyses were based on 20 437 cataract extractions reported during 1 month each
year to the outcome registry of the NCR. Cataract surgery was found to reduce IOP by a mean of
1.46 mm Hg, which was statistically significant (P < .001). A larger IOP reduction was seen in cases
with a higher preoperative IOP (r Z 0.557, P < .001). Older patients and shorter eyes had a greater
IOP reduction after surgery (P < .001 and P Z .001, respectively). Women had a greater IOP reduc-
tion than men (P Z .04) When high IOP was given as an indication for surgery, the IOP reduction
after cataract surgery was 5.50 mm Hg compared with a reduction of 1.40 mm Hg in patients for
whom this indication was not given (P < .001). Patients with glaucoma or pseudoexfoliation (PXF)
had a more pronounced IOP reduction than patients without these diagnoses (P < .001).
CONCLUSION: Cataract surgery had an IOP-lowering effect, in particular in older patients, women,
short eyes, eyes with high preoperative IOP, and eyes with glaucoma or PXF.
Financial Disclosure: No author has a financial or proprietary interest in any material or method
mentioned.
J Cataract Refract Surg 2015; 41:1725–1729 Q 2015 ASCRS and ESCRS
Cataract surgery is one of the most common surgical the development and progression of glaucoma.3 Intra-
procedures performed, with steadily increasing ocular pressure–lowering therapy significantly delays
rates.1 In the past, cataract was the major cause of progression, as shown in the Early Manifest Glaucoma
visual impairment and blindness, even in high- Trial program.4
income countries. Today, with increasing cataract The aim of this study was to analyze changes in IOP
surgery performed in these countries, age-related after cataract surgery using data from the Swedish
macular degeneration and uncorrected refractive National Cataract Register (NCR).
error are the main causes of visual impairment.2
The incidence of both cataract and elevated intraoc-
MATERIALS AND METHODS
ular pressure (IOP), with or without glaucoma,
increases with age. This database study was based on the NCR and its outcome
registry. The NCR was started in 1992.5 Today, almost all
Intraocular pressure remains the only known modi- units performing cataract surgery in Sweden report to the
fiable risk factor in the management of glaucoma NCR, with coverage of 96% to 97%. Phacoemulsification is
and is well recognized as a primary risk factor for the technique used in 99% of cases.6
Table 3. Multivariable test of the relationship between preoperative variables and IOP reduction after a cataract extraction.*
Exponentiation of B
Glaucoma was the most common diagnosis when previously been suggested that phacoemulsification
the indication was elevated IOP, and IOP reduction has a protective effect concerning glaucoma progres-
in this patient group was larger than in the group of sion in eyes with PXF. This was thought to be because
patients who did not have glaucoma. Performing cata- of the IOP-lowering effect of the lens exchange.24
ract extraction before glaucoma surgery has numerous Limitations of our study are its short follow-up and
benefits, and this procedure has been found to be that neither locally administered ocular corticosteroids
appropriate in selected cases.19,21 In an earlier study,21 nor glaucoma medications were known. However, the
50% of eyes with mild to moderate open-angle glau- data from the follow-up visit are taken from the NCR’s
coma had an unmedicated IOP of 21 mm Hg or less outcome registry, to which surgical units report their
1 year after cataract surgery. One inclusion criterion follow-up control. This takes somewhere between a
in that study was an IOP of 24 mm Hg or less few days to 1 month in Sweden. Because this was a
controlled with 1 to 3 medications. database study, we have to accept different routines
Eyes with PXF have a higher risk for developing both in different settings. Also, to our knowledge, most sur-
nuclear cataract and glaucoma22,23 and also have a gical clinics in Sweden administer corticosteroids
higher IOP than controls.8 In our analysis of NCR drops for 3 to 4 weeks after cataract surgery, and
data, we found that when elevated IOP was an indica- IOP changes from corticosteroid drops often occur
tion for cataract surgery, 35.3% of eyes had PXF. It has later.25 The protocol does not include questions con-
cerning glaucoma medication, and this is a limitation.
Table 4. Reduction in IOP after cataract surgery in eyes with However, modification of this medication during the
indication of elevated IOP, glaucoma, and PXF according to short follow-up does not happen very often.
data from the Swedish NCR (indications) and the outcome reg-
In summary, phacoemulsification had an IOP-
istry of the NCR (outcomes).
lowering effect, particularly in older patients, women,
IOP Reduction short eyes, and eyes with high preoperative IOP, glau-
(mm Hg) coma, or PXF.
Characteristic Patients (n) Mean 95% CI P Value*
Indication of !.001
elevated IOP WHAT WAS KNOWN
Yes 286 5.50 4.68, 6.33 Cataract surgery has an IOP-lowering effect in normal
No 20 151 1.40 1.35, 1.45 eyes, eyes with ocular hypertension, and eyes with
Glaucoma !.001
glaucoma.
Yes 1842 2.28 2.04, 2.53
No 18 595 1.38 1.33, 1.43 A greater reduction in IOP occurs in eyes with high preop-
PXF !.001 erative IOP.
Yes 1903 2.30 2.09, 2.51
No 18 534 1.37 1.32, 1.42
Glaucoma and !.001 WHAT THIS PAPER ADDS
pseudoexfoliation
A more pronounced IOP-lowering effect after cataract sur-
Yes 490 2.53 1.98, 3.07
No 19 947 1.43 1.38, 1.48
gery was found in older patients, women, and eyes with a
short AL.
CI Z confidence interval; IOP Z intraocular pressure; PXF Z
pseudoexfoliation The prospective database study showed the IOP-lowering
*Independent-samples t test effect after cataract surgery in a large population.
REFERENCES 14. Doyle L, Little JA, Saunders KJ. Repeatability of OCT lens thick-
ness measures with age and accommodation. Optom Vis Sci
1. Gollogly HE, Hodge DO, St. Sauver JL, Erie JC. Increasing inci-
2013; 90:1396–1405. Available at: http://journals.lww.com/opt
dence of cataract surgery: population-based study. J Cataract
vissci/Fulltext/2013/12000/Repeatability_of_OCT_Lens_Thick
Refract Surg 2013; 39:1383–1389
ness_Measures_With.9.aspx. Accessed June 17, 2015
2. Bourne RRA, Jonas JB, Flaxman SR, Keeffe J, Leasher J,
15. Sun JH, Sung KR, Yun SC, Cheon MH, Tchah HW, Kim MJ,
Naidoo K, Parodi MB, Pesudovs K, Price H, White RA,
Kim JY. Factors associated with anterior chamber narrowing
Wong TY, Resnikoff S, Taylor HR; on behalf of the Vision Loss
with age: an optical coherence tomography study. Invest Oph-
Expert Group of the Global Burden of Disease Study. Preva-
thalmol Vis Sci 2012; 53:2607–2610. Available at: http://iovs.arvo
lence and causes of vision loss in high-income countries and
journals.org/article.aspx?articleidZ2127302. Accessed June
in Eastern and Central Europe: 1990–2010. Br J Ophthalmol
17, 2015
2014; 98:629–638
16. Seki M, Fukuchi T, Ueda J, Suda K, Nakatsue T, Tanaka Y,
3. Rossetti L, Goni F, Denis P, Bengtsson B, Martinez A, Heijl A.
Togano T, Yamamoto S, Hara H, Abe H. Nanophthalmos:
Focusing on glaucoma progression and the clinical importance
quantitative analysis of anterior chamber angle configuration
of progression rate measurement: a review. Eye 2010; 24(suppl
before and after cataract surgery. Br J Ophthalmol 2012;
1):S1–S7. Available at: http://www.nature.com/eye/journal/v24/
96:1108–1116
n1s/pdf/eye2010112a.pdf. Accessed June 17, 2015
17. Behndig A, Montan P, Lundstro €m M, Zetterstro €m C,
4. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B,
Kugelberg M. Gender differences in biometry prediction error
Hussein M; for the Early Manifest Glaucoma Trial Group. Reduc-
and intra-ocular lens power calculation formula. Acta Ophthal-
tion of intraocular pressure and glaucoma progression; results
mol 2014; 92:759–763
from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;
18. Emanuel ME, Parrish RK II, Gedde SJ. Evidence-based man-
120:1268–1279. Available at: http://archopht.jamanetwork.com/
agement of primary angle closure glaucoma. Curr Opin Ophthal-
data/Journals/OPHTH/6834/ECS20122.pdf. Accessed June 17,
mol 2014; 25:89–92
2015
€m M. 19. Shrivastava A, Singh K. The impact of cataract surgery on glau-
5. Behndig A, Montan P, Stenevi U, Kugelberg M, Lundstro
coma care. Curr Opin Ophthalmol 2014; 25:19–25
One million cataract surgeries: Swedish National Cataract Reg-
20. Mansberger SL, Gordon MO, Jampel H, Bhorade A, Brandt JD,
ister 1992 2009. J Cataract Refract Surg 2011; 37:1539–1545
€m M, Behndig A, Kugelberg M, Montan P, Stenevi U, Wilson B, Kass MA; for the Ocular Hypertension Treatment
6. Lundstro
Study Group. Reduction in intraocular pressure after cataract
Thorburn W. Decreasing rate of capsule complications in cata-
extraction: the Ocular Hypertension Treatment Study. Ophthal-
ract surgery; eight-year study of incidence, risk factors, and
mology 2012; 119:1826–1831. Available at: http://www.ncbi.
data validity by the Swedish National Cataract Register.
nlm.nih.gov/pmc/articles/PMC3426647/pdf/nihms361980.pdf.
J Cataract Refract Surg 2011; 37:1762–1767
Accessed June 17, 2015
7. Slabaugh MA, Chen PP. The effect of cataract extraction on
21. Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE;
intraocular pressure. Curr Opin Ophthalmol 2014; 25:122–126
€m S, Stenlund H, Linde n C. Intraocular pressure changes for the US iStent Study Group. Randomized evaluation of the
8. Åstro
trabecular micro-bypass stent with phacoemulsification in pa-
over 21 years a longitudinal age-cohort study in northern Swe-
tients with glaucoma and cataract. Ophthalmology 2011;
den. Acta Ophthalmol 2014; 92:417–420
118:459–467
9. Shin HC, Subrayan V, Tajunisah I. Changes in anterior chamber
22. Schlo€tzer-Schrehardt U, Naumann GOH. Ocular and systemic
depth and intraocular pressure after phacoemulsification in eyes
pseudoexfoliation syndrome. Am J Ophthalmol 2006;
with occludable angles. J Cataract Refract Surg 2010; 36:1289–
141:921–937
1295
23. Kanthan GL, Mitchell P, Burlutsky G, Rochtchina E, Wang JJ.
10. Poley BJ, Lindstrom RL, Samuelson TW, Schulze R Jr. Intraoc-
Pseudoexfoliation syndrome and the long-term incidence of
ular pressure reduction after phacoemulsification with intraoc-
cataract and cataract surgery: the Blue Mountains Eye Study.
ular lens implantation in glaucomatous and nonglaucomatous
Am J Ophthalmol 2013; 155:83–88
eyes; evaluation of a causal relationship between the natural
24. Shingleton BJ, Laul A, Nagao K, Wolff B, O’Donoghue M,
lens and open-angle glaucoma. J Cataract Refract Surg 2009;
Eagan E, Flattem N, Desai-Bartoli S. Effect of phacoemulsifi-
35:1946–1955
cation on intraocular pressure in eyes with pseudoexfoliation:
11. Yang HS, Lee J, Choi S. Ocular biometric parameters associ-
single-surgeon series. J Cataract Refract Surg 2008;
ated with intraocular pressure reduction after cataract surgery
34:1834–1841
in normal eyes. Am J Ophthalmol 2013; 156:89–94
25. McGhee CNJ, Dean S, Danesh-Meyer H. Locally administered
12. Huang G, Gonzalez E, Lee R, Chen YC, He M, Lin SC. Associ-
ocular corticosteroids; benefits and risks. Drug Saf 2002;
ation of biometric factors with anterior chamber angle widening
25:33–55
and intraocular pressure reduction after uneventful phacoemul-
sification for cataract. J Cataract Refract Surg 2012; 38:108–116
13. Huang G, Gonzalez E, Peng PH, Lee R, Leeungurasatien T,
He M, Porco T, Lin SC. Anterior chamber depth, iridocorneal First author:
angle width, and intraocular pressure changes after phacoemul- Charlotta Zetterstr€
om, MD, PhD
sification; narrow vs open iridocorneal angles. Arch Ophthalmol
2011; 129:1283–1290. correction, 1497. Available at: http:// Department of Clinical Neuroscience,
archopht.jamanetwork.com/data/Journals/OPHTH/22546/ecs1 Division of Ophthalmology and Vision,
5024_1283_1290.pdf. Correction available at: http://arch Karolinska Institutet, Stockholm,
opht.jamanetwork.com/data/Journals/OPHTH/22547/ecx150 Sweden
10_1497_1497.pdf. Accessed June 17, 2015